Ardsley Advisory Partners’s Amgen AMGN Stock Holding History

Ardsley Advisory Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$608K	–	137
2020 Q1	$608K	Buy	+3,000	New	+$655K	0.24%	56
2017 Q2	–	Sell	-2,000	Closed	-$328K	–	137
2017 Q1	$328K	Buy	+2,000	New	+$332K	0.05%	117
2013 Q3	–	Sell	-3,500	Closed	-$345K	–	142
2013 Q2	$345K	Buy	+3,500	New	+$363K	0.08%	94

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ardsley Advisory Partners's AMGN Position: Q2 2020 in Review

Ardsley Advisory Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 3,000 shares — an estimated $608K sold.

Ardsley Advisory Partners first reported a position in AMGN in Q2 2013 and held it in 3 quarters. The position peaked at $608K in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

Ardsley Advisory Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
Ardsley Advisory Partners sold 3,000 Amgen shares in Q2 2020, an estimated $608K.
Ardsley Advisory Partners first reported a position in Amgen in Q2 2013 and held it in 3 quarters.
Ardsley Advisory Partners's Amgen position peaked at $608K in Q1 2020.
2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Ardsley Advisory Partners's 13F filing for Q2 2020, filed 14 Aug 2020.